Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Assessing the clinical value of targeted massively parallel sequencing in a longitudinal, prospective population-based study of cancer patients.

British journal of cancer - 14 Apr 2015

Wong S Q, Fellowes A, Doig K, Ellul J, Bosma T J, Irwin D, Vedururu R, Tan A Y-C, Weiss J, Chan K S, Lucas M, Thomas D M, Dobrovic A, Parisot J P, Fox S B

Abstract excerpt

INTRODUCTION: Recent discoveries in cancer research have revealed a plethora of clinically actionable mutations that provide therapeutic, prognostic and predictive benefit to patients. The feasibility of screening mutations as part of the routine clinical care of patients remains relatively unexplored as the demonstration of massively parallel sequencing (MPS) of tumours in the general population is required to...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to DNA Mutational Analysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to DNA, Neoplasm

Share to High-Throughput Nucleotide Sequencing

Share to Longitudinal Studies

Share to Mutation

Share to Neoplasm Proteins

Share to Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 25742471
DOI: 10.1038/bjc.2015.80
PMCID: PMC4402458

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Assessing the clinical value of targeted massively parallel sequencing in a longitudinal, prospective population-based study of cancer patients.PMID 25742471Read ↗

Rapid targeted mutational analysis of human tumours: a clinical platform to guide personalized cancer medicine.Semantic proximity Read ↗

Validation and utilisation of high-coverage next-generation sequencing to deliver the pharmacological audit trail.Semantic proximity Read ↗

Computational optimisation of targeted DNA sequencing for cancer detection.Semantic proximity Read ↗

High-Throughput Detection of Actionable Genomic Alterations in Clinical Tumor Samples by Targeted, Massively Parallel SequencingSemantic proximity Read ↗

Investigating the feasibility of tumour molecular profiling in gastrointestinal malignancies in routine clinical practice.Semantic proximity Read ↗

Clinically actionable mutation profiles in patients with cancer identified by whole-genome sequencing.Semantic proximity Read ↗

Clinical actionability enhanced through deep targeted sequencing of solid tumors.Semantic proximity Read ↗

Sequence artefacts in a prospective series of formalin-fixed tumours tested for mutations in hotspot regions by massively parallel sequencing.Semantic proximity Read ↗

Personalized genomic analyses for cancer mutation discovery and interpretation.Semantic proximity Read ↗

Comparison of actionable events detected in cancer genomes by whole-genome sequencing, in silico whole-exome and mutation panels.Semantic proximity Read ↗

Introducing whole-genome sequencing into routine cancer care: the Genomics England 100 000 Genomes ProjectSemantic proximity Read ↗

Next-generation sequencing-based evaluation of the actionable landscape of genomic alterations in solid tumors: the "MOZART" prospective observational study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.